NASDAQ: INAB
In8bio Inc Stock Ownership - Who owns In8bio?

Insider buying vs selling

Have In8bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INAB insiders and whales buy or sell their stock.

INAB Shareholders

What type of owners hold In8bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher11.81%9,597,434$1.65MInsider
Leslie W. Kreis11.81%9,597,434$1.65MInsider
Bios Capital Management LP10.58%8,600,001$1.48MInstitution
Aigh Capital Management LLC7.62%6,191,865$1.07MInstitution
Franklin Resources Inc7.01%5,696,202$979.75kInstitution
Alyeska Investment Group LP6.23%5,063,291$870.89kInstitution
William Taiwei Ho3.27%2,657,594$457.11kInsider
Vanguard Group Inc1.75%1,423,897$244.91kInstitution
Sigma Planning Corp1.28%1,041,380$179.12kInstitution
683 Capital Management LLC0.92%750,000$129.00kInstitution

1 of 3

INAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INAB36.96%28.41%
CLDI3.87%65.47%Net Buying
BOLT48.33%51.67%
MEIP15.70%84.30%Net Buying
KAPA2.44%40.60%Net Buying

In8bio Stock Ownership FAQ

Who owns In8bio?

In8bio (NASDAQ: INAB) is owned by 36.96% institutional shareholders, 28.41% In8bio insiders, and 34.64% retail investors. Aaron Gl Fletcher is the largest individual In8bio shareholder, owning 9.60M shares representing 11.81% of the company. Aaron Gl Fletcher's In8bio shares are currently valued at $1.62M.

If you're new to stock investing, here's how to buy In8bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.